Neuronetics Inc
NASDAQ:STIM
Neuronetics Inc
NASDAQ:STIM
Price:
3.555 USD
5.49%
Market Closed
Updated:
May 2, 2024
Section:
Relative Value
The Relative Value of one
STIM
stock under the Base Case scenario is
4.819
USD.
Compared to the current market price of 3.555 USD,
Neuronetics Inc
is
Undervalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
STIM
Relative Value
Base Case
4.819
USD
Undervaluation 26%
Valuation Multiples
Multiples Across Competitors
STIM Competitors Multiples
Neuronetics Inc Competitors
Neuronetics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Neuronetics Inc
NASDAQ:STIM
|
103.4m USD | 1.4 | -3.4 | -3.6 | -3.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
185B USD | 4.6 | 32.9 | 19.4 | 28.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.2B USD | 18.1 | 66.5 | 54.5 | 68.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.9B USD | 6 | 39.1 | 24.5 | 30.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108B USD | 3.3 | 25.7 | 13.7 | 19.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.4 | 67.3 | 31.3 | 46.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 3.5 | 55.5 | 18.6 | 39.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | 38.3 | 18.4 | 31 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.7B USD | 8.4 | 36.1 | 26.1 | 28.3 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49B USD | 13.5 | 90.5 | 61 | 79.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
